Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ABEMACICLIB vs ACAMPROSATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ABEMACICLIB vs ACAMPROSATE: Safety Overview

Metric ABEMACICLIB ACAMPROSATE
Total FAERS Reports 16,389 524
Deaths Reported 1,243 53
Death Rate 7.6% 10.1%
Hospitalizations 3,635 290
Average Patient Age 60.5 yrs 51.7 yrs
% Female Patients 97.4% 36.9%
FDA Approval Date Sep 28, 2017 Jul 16, 2013
Manufacturer Eli Lilly and Company American Health Packaging
Route ORAL ORAL
Marketing Status Prescription Discontinued